We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · September 20, 2022

Treatment of Atopic Dermatitis With Dupilumab Prevents the Progression of Atopic March

Journal of Allergy and Clinical Immunology

 

Additional Info

Journal of Allergy and Clinical Immunology
Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events
J. Allergy Clin. Immunol 2022 Sep 06;[EPub Ahead of Print], GP Geba, D Li, M Xu, K Mohammadi, R Attre, M Ardeleanu, B Musser

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading